Amorepacific FY 2025 Annual ReportBeta
Amorepacific annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 18, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).
Amorepacific FY 2025 Annual Report Analysis
Business Overview
- • 2025 consolidated revenue KRW 4.25T, up 9.5% YoY; operating profit KRW 336B, up 52.3% YoY
- • Newly acquired subsidiaries: Cosrx acquired April 2024, Tata's Natural Alchemy acquisition completed Oct 2022
Management Discussion & Analysis
- • Revenue KRW 4.25T (+9.5% YoY), operating profit KRW 336B (+52.3%), net income KRW 247B (-58.9% from prior year)
- • Overseas business revenue up 14.7% driven by U.S. market 20% sales growth; management cites "Lanerèze lip new product launch and expanded skincare marketing"
Risk Factors
- • FX hedging through currency futures with no derivative assets or liabilities reported in FY2025
- • Derivative trading profit KRW 4.845B in FY2025, down from KRW 8.208B in FY2024
Amorepacific FY 2025 Key Financial MetricsDART
Total Assets
KRW 6.96T
▲ +2.6% YoY
Operating Cash Flow
KRW 583.8B
▲ +74.5% YoY
CapEx
KRW 64.6B
▼ -20.2% YoY
Source: KIFRS consolidated financial data from Amorepacific annual report on DART. All figures in KRW.
Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding